AUPH (Aurinia Pharmaceuticals) Short-Term Debt to Capital
The Aurinia Pharmaceuticals (AUPH) price chart on GURU.Markets reflects the dynamics of a specialized biopharma company whose revenue is based on the sale of an approved lupus nephritis treatment, with the metric standing at 0.03. Peter Greenleaf aims to maximize the product's commercial success by reducing costs. Following unsuccessful attempts to sell the business, Aurinia Pharmaceuticals (AUPH) shifted toward aggressive cost-cutting and independent drug promotion.
Analytical breakdowns for Aurinia Pharmaceuticals
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Aurinia Pharmaceuticals|AUPH - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Aurinia Pharmaceuticals Inc.|AUPH - Aggregate Debt Obligations|Debts to Book Capitalization Aurinia Pharmaceuticals Inc|AUPH - Long-Term Debt Volume|Company Short-Term Debt Aurinia Pharmaceuticals|Quick Liquidity auriniapharma.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Aurinia Pharma
Amid market volatility, capital protection requires strict monitoring of liabilities maturing within one year relative to equity. Since Aurinia Pharmaceuticals (AUPH) has outsourced production to third-party contractors, the short-term leverage ratio is critical for assessing liquidity when settling with vendors, allowing investors to determine the business's dependence on short-term debt financing and the overall resilience of the portfolio.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital DNTH (Dianthus Pharma)|Short-Term Debt to Capital Coefficient Pharvaris Pharma (PHVS)|ABCL - Short-Term Debt to Equity|tourmalinebio.com (TRML) - Short-Term Debt to Equity Ratio|Precigen (PGEN) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Pharming Group NV|Short-Term Debt to Equity Ratio NKTR|Short-Term Debt to Capital Upstream Pharma|Short-Term Debt to Equity Zenas Biopharma Inc (ZBIO)|immunome.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Current Liabilities to Capital|Septerna Corp - Short-Term Debt to Capital|PVLA - Short-Term Debt to Capital|SVRA (Savara Inc.) - Short-Term Debt to Equity Ratio|rigel.com (RIGL) - Short-Term Debt to Capital|Short-Term Debt to Equity AnaptysBio|ATXS: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ENGN|Short-Term Debt to Capital Coefficient rapt.com|Short-Term Debt to Equity Aerovate Therapeutics JBIO|ACRS: Short-Term Debt to Capital Ratio|Kyverna Therapeutics, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Tiziana Life Sciences Ltd. TLSA|CABA: Short-Term Debt to Capital|Ventyx Biosciences, Inc (VTYX) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio THTX|AVTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Eledon Pharmaceuticals, Inc. (ELDN)|AGEN: Current Liabilities to Equity|Short-Term Debt to Capital CLYM (Climb Bio, Inc.)|Ratio of Short-Term Indebtedness to Capital ZURA|aTyr Pharma, Inc. - Short-Term Debt to Capital|ADAG - Short-Term Debt to Capital|ikenaoncology.com (IMA) - Short-Term Debt to Equity|Shattuck Labs - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Equillium Inc|Short-Term Debt to Equity Ratio Connect Pharma (CNTB)|Short-Term Debt to Capital IMUX|Short-Term Debt to Capital atarabio.com (ATRA)|Short-Term Debt to Capital IFRX (InflaRx)|XFOR - Short-Term Debt to Equity Ratio|Adicet - Short-Term Debt to Capital|Current Liabilities to Capital Celularity Inc.|INMB (INmune Bio, Inc.) - Short-Term Debt to Equity Ratio|barinthusbio.com (BRNS) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio KZR|SABS (SAB Biotherapeutics Inc.) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital AKTX|Short-Term Debt to Capital Coefficient enlivex.com|Short-Term Debt to Capital QTTB (Q32 Bio)|GOVX - Short-Term Debt to Equity Ratio|Edesa Biotech - Short-Term Debt to Capital|IBIO - Short-Term Debt to Capital|carismatx.com (CARM) - Short-Term Debt to Equity|XTLB (XTL Bio) - Short-Term Debt to Equity|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|HCW Biologics Inc (HCWB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital APVO|Short-Term Debt to Capital aimimmuno.com (AIM)|Aditxt, Inc. - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital GRI Bio Corporation GRI|XRTX - Short-Term Debt to Equity|Current Liabilities to Equity HIND|REVB: Short-Term Debt to Capital|Indaptus Therapeutics Inc - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Scinai|CalciMedica Corp - Current Liabilities to Equity|Short-Term Debt to Capital AFMD|ALLK (allakos.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital IGM Biosciences Inc. IGMS|ITOS - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital OCEA (Ocean Biomedical Corp)|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio thirdharmonicbio.com